SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053333
Filing Date
2020-11-12
Accepted
2020-11-12 09:00:55
Documents
75
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvmd-10q_20200930.htm 10-Q 3344541
2 EX-31.1 rvmd-ex311_6.htm EX-31.1 17977
3 EX-31.2 rvmd-ex312_8.htm EX-31.2 18148
4 EX-32.1 rvmd-ex321_9.htm EX-32.1 8493
5 EX-32.2 rvmd-ex322_7.htm EX-32.2 8544
  Complete submission text file 0001564590-20-053333.txt   10657657

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rvmd-20200930.xml EX-101.INS 2350254
7 XBRL TAXONOMY EXTENSION SCHEMA rvmd-20200930.xsd EX-101.SCH 69269
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rvmd-20200930_cal.xml EX-101.CAL 74596
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvmd-20200930_def.xml EX-101.DEF 206273
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmd-20200930_lab.xml EX-101.LAB 519858
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmd-20200930_pre.xml EX-101.PRE 388136
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39219 | Film No.: 201303804
SIC: 2836 Biological Products, (No Diagnostic Substances)